Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Evgen Pharma PLC (GB:EVG)
LSE:EVG
Evgen Pharma (EVG) Share Price & Analysis
0 Followers
EVG Stock Chart & Stats
Day’s Range0.75p - 0.81p
52-Week Range― - ―
Previous Close0.8p
Volume144.98K
Average Volume (3M)N/A
Market Cap
£3.42M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)N/A
BetaN/A
Next Earnings
Jun 12, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Evgen Pharma News
PremiumCompany Announcements
Evgen Pharma Rebrands as TheraCryf PLC
PremiumCompany Announcements
Vulpes Investment Changes Stake in Evgen PharmaOptions Prices
Currently, No data available
---
Ownership Overview
2.65% Insiders
0.00% Mutual Funds
0.00% Other Institutional Investors
97.35% Public Companies and
Individual Investors
EVG FAQ
What was Evgen Pharma PLC’s price range in the past 12 months?
Currently, no data Available
What is Evgen Pharma PLC’s market cap?
Currently, no data Available
When is Evgen Pharma PLC’s upcoming earnings report date?
Evgen Pharma PLC’s upcoming earnings report date is Jun 12, 2024 which is in 43 days.
How were Evgen Pharma PLC’s earnings last quarter?
Evgen Pharma PLC released its earnings results on Oct 31, 2023. The company reported -0.005p earnings per share for the quarter, missing the consensus estimate of N/A by -0.005p.
Is Evgen Pharma PLC overvalued?
According to Wall Street analysts Evgen Pharma PLC’s price is currently Overvalued.
Does Evgen Pharma PLC pay dividends?
Evgen Pharma PLC does not currently pay dividends.
What is Evgen Pharma PLC’s EPS estimate?
Evgen Pharma PLC’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Evgen Pharma PLC have?
Currently, no data Available
What happened to Evgen Pharma PLC’s price movement after its last earnings report?
Evgen Pharma PLC reported an EPS of -0.005p in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Evgen Pharma PLC?
Currently, no hedge funds are holding shares in GB:EVG
---
Evgen Pharma Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-78.66%
12-Months-Change
Fundamentals
Return on Equity
-60.57%
Trailing 12-Months
Asset Growth
-42.54%
Trailing 12-Months
Company Description
Evgen Pharma PLC
Evgen Pharma PLC is a UK-based clinical-stage drug development company. The company is focused on the development of sulforaphane-based compounds. Its core technology is Sulforadex, which synthesis and stabilizes the naturally occurring compound sulforaphane. Geographically, it operates only in the United Kingdom. It is engaged in the treatment of breast cancer and Subarachnoid Haemorrhage.
---
Technical Analysis
C4X Discovery Holdings
―
HemoGenyx Pharmaceuticals Plc
―
Genedrive
―
OptiBiotix Health
―
---